Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Dyslipidemia

Free Subscription Articles published in PLoS One Retrieve available abstracts of 170 articles: HTML format

Single Articles

January 2024
1. ALBASSAM AA, Alenzi AN, Alhaqbani NK, Alhouty FK, et al
   Beliefs, awareness, use, and factors associated with herbal supplements usage among patients with chronic diseases-A cross-sectional insight from Alkharj, Saudi Arabia.
   PLoS One. 2024;19:e0295116.
   PubMed     Abstract available
   
   
   
2. ABD RAHIM IN, Mohd Kasim NA, Omar E, Abdul Muid S, et al
   Safety evaluation of saffron extracts in early and established atherosclerotic New Zealand white rabbits.
   PLoS One. 2024;19:e0295212.
   PubMed     Abstract available
   
   
   
3. LE-DANG MA, Nguyen-Thi HY, Dinh LP, Ngoc DL, et al
   Impact of COVID-19 on patterns of drug utilization: A case study at national hospital.
   PLoS One. 2024;19:e0297187.
   PubMed     Abstract available
   
   
   
4. LI Y, Gao H, Zhao J, Ma L, et al
   Safety and efficacy of bempedoic acid among patients with statin intolerance and those without: A meta-analysis and a systematic randomized controlled trial review.
   PLoS One. 2024;19:e0297854.
   PubMed     Abstract available
   
   
   
5. JUNG HH
   Blood pressure control in patients aged above and below 75 years.
   PLoS One. 2024;19:e0297103.
   PubMed     Abstract available
   
   
   
6. MATUTE I, Castillo-Laborde C
   Prescription drug coverage and effective coverage of three chronic conditions of high prevalence in Chile: Hypertension, diabetes and dyslipidemia.
   PLoS One. 2024;19:e0297807.
   PubMed     Abstract available
   
   
   
7. NAM DW, Park MH, Jeong SJ, Lee KL, et al
   Sex differences in associated factors for age-related hearing loss.
   PLoS One. 2024;19:e0298048.
   PubMed     Abstract available
   
   
   
8. LUTZHOFT DO, Baekgard C, Wimborne E, Straarup EM, et al
   High fat diet is associated with gut microbiota dysbiosis and decreased gut microbial derived metabolites related to metabolic health in young Gottingen Minipigs.
   PLoS One. 2024;19:e0298602.
   PubMed     Abstract available
   
   
   
9. LIU LP, Wariboko MA, Hu X, Wang ZH, et al
   Factors associated with early-onset androgenetic alopecia: A scoping review.
   PLoS One. 2024;19:e0299212.
   PubMed     Abstract available
   
   
   
10. XU S, Shiomi H, Yamashita Y, Koyama S, et al
    CRISPR-Cas9-guided amplification-free genomic diagnosis for familial hypercholesterolemia using nanopore sequencing.
    PLoS One. 2024;19:e0297231.
    PubMed     Abstract available
    
    
    
11. LUVIANO-GARCIA JA, Loose-Esparza A, Hernandez-Ruiz YG, Sanz-Sanchez MA, et al
    Risk factors for intubation and mortality in patients treated with high flow nasal cannula due to COVID-19 infection. Survival Analysis Study in a Northern Mexican Population.
    PLoS One. 2024;19:e0296931.
    PubMed     Abstract available
    
    
    
12. LEE T, Han K, Yun KI
    Association between dental scaling and metabolic syndrome and lifestyle.
    PLoS One. 2024;19:e0297545.
    PubMed     Abstract available
    
    
    January 2023
13. CHOY CC, Nyhan K, Savusa K, Soti-Ulberg C, et al
    Scoping review protocol of multicomponent interventions to address cardiometabolic disease risk among Pacific Islander children.
    PLoS One. 2023;18:e0280888.
    PubMed     Abstract available
    
    
    
14. ALI N, Samadder M, Kathak RR, Islam F, et al
    Prevalence and factors associated with dyslipidemia in Bangladeshi adults.
    PLoS One. 2023;18:e0280672.
    PubMed     Abstract available
    
    
    
15. WU J, Zou L, Liu Y, Yu H, et al
    Association between obesity indicators and cardiometabolic disease in Chinese adults.
    PLoS One. 2023;18:e0273235.
    PubMed     Abstract available
    
    
    
16. AL FARAIDY K, Akbar M, Shehri M, Aljarallah M, et al
    Multizonal observational study conducted by clinical practitioners on evolocumab use in subjects with hyperlipidemia in Saudi Arabia and Kuwait: Results from the ZERBINI study.
    PLoS One. 2023;18:e0278821.
    PubMed     Abstract available
    
    
    
17. AL-ASHWAL FY, Sulaiman SAS, Sheikh Ghadzi SM, Kubas MA, et al
    Physicians and pharmacists' clinical knowledge of statin therapy and monitoring parameters, and the barriers to guideline implementation in clinical practice.
    PLoS One. 2023;18:e0280432.
    PubMed     Abstract available
    
    
    
18. MOHAMMED O, Alemayehu E, Ebrahim E, Fiseha M, et al
    Atherogenic dyslipidemia and associated risk factors among hypertensive patients of five health facilities in Northeast Ethiopia.
    PLoS One. 2023;18:e0277185.
    PubMed     Abstract available
    
    
    
19. DE OLIVEIRA CM, Bolognese LB, Balcells M, Aragon DC, et al
    A data-driven approach to manage type 2 diabetes mellitus through digital health: The Klivo Intervention Program protocol (KIPDM).
    PLoS One. 2023;18:e0281844.
    PubMed     Abstract available
    
    
    
20. LUI G, Leung HS, Lee J, Wong CK, et al
    An efficient approach to estimate the risk of coronary artery disease for people living with HIV using machine-learning-based retinal image analysis.
    PLoS One. 2023;18:e0281701.
    PubMed     Abstract available
    
    
    
21. ALAHMAD MM, ZainAlAbdin S, AlAhmad K, AlAhmad I, et al
    Value of the clinical pharmacist interventions in the application of the American College of Cardiology (ACC/AHA) 2018 guideline for cholesterol management.
    PLoS One. 2023;18:e0283369.
    PubMed     Abstract available
    
    
    
22. OHN K, Han K, Moon JI, Jung Y, et al
    Presence and severity of migraine is associated with development of primary open angle glaucoma: A population-based longitudinal cohort study.
    PLoS One. 2023;18:e0283495.
    PubMed     Abstract available
    
    
    
23. SONG DK, Hong YS, Sung YA, Lee H, et al
    The effect of menopause on cardiovascular risk factors according to body mass index in middle-aged Korean women.
    PLoS One. 2023;18:e0283393.
    PubMed     Abstract available
    
    
    
24. JO EJ, Lee YU, Kim A, Park HK, et al
    The prevalence of multiple chronic conditions and medical burden in asthma patients.
    PLoS One. 2023;18:e0286004.
    PubMed     Abstract available
    
    
    
25. MORI Y, Matsushita K, Inoue K, Fukuma S, et al
    Patterns and predictors of adherence to follow-up health guidance invitations in a general health check-up program in Japan: A cohort study with an employer-sponsored insurer database.
    PLoS One. 2023;18:e0286317.
    PubMed     Abstract available
    
    
    
26. SHIN H, Shim S, Oh S
    Machine learning-based predictive model for prevention of metabolic syndrome.
    PLoS One. 2023;18:e0286635.
    PubMed     Abstract available
    
    
    
27. SAPKOTA BP, Baral KP, Rehfuess EA, Parhofer KG, et al
    Effects of age on non-communicable disease risk factors among Nepalese adults.
    PLoS One. 2023;18:e0281028.
    PubMed     Abstract available
    
    
    
28. CHANG KC, Pai YW, Lin CH, Lee IT, et al
    The association between hyperlipidemia, lipid-lowering drugs and diabetic peripheral neuropathy in patients with type 2 diabetes mellitus.
    PLoS One. 2023;18:e0287373.
    PubMed     Abstract available
    
    
    
29. CHEN PT, Zhang HW, Tsai ZR, Peng HC, et al
    Association between hyperlipidemia and trigger finger: A nationwide population-based cohort study.
    PLoS One. 2023;18:e0288426.
    PubMed     Abstract available
    
    
    
30. BHANDARI P
    Prevalence of cardiovascular risk factors among Asian migrant workers in South Korea.
    PLoS One. 2023;18:e0288375.
    PubMed     Abstract available
    
    
    
31. VAINSHELBOIM B, Myers J
    Dyslipidemia paradox: Analysis from the veterans exercise testing study.
    PLoS One. 2023;18:e0287923.
    PubMed     Abstract available
    
    
    
32. ZHANG J, Olsen A, Halkjaer J, Petersen KE, et al
    Self-reported and measured anthropometric variables in association with cardiometabolic markers: A Danish cohort study.
    PLoS One. 2023;18:e0279795.
    PubMed     Abstract available
    
    
    
33. BOROWIEC A, Ozdowska P, Rosinska M, Jagiello-Gruszfeld A, et al
    Prognostic value of coronary atherosclerosis and CAC score for the risk of chemotherapy-related cardiac dysfunction (CTRCD): The protocol of ANTEC study.
    PLoS One. 2023;18:e0288146.
    PubMed     Abstract available
    
    
    
34. BERHE KK, Mselle LT, Gebru HB
    The magnitude of chronic diabetes complications and its associated factors among diabetic patients attending the general hospitals in Tigray region, Northern Ethiopia.
    PLoS One. 2023;18:e0290240.
    PubMed     Abstract available
    
    
    
35. ALJEHANI R, Aljehani G, Alharazi H, Horta PM, et al
    The Mediterranean Diet Scale (MDS): Translation and validation of the Arabic version.
    PLoS One. 2023;18:e0287497.
    PubMed     Abstract available
    
    
    
36. XU S, Yang X, Liu J, Chong MK, et al
    Health and wellbeing among the empty nest and non-empty nest elderly in China-Results from a national cross-sectional study.
    PLoS One. 2023;18:e0291231.
    PubMed     Abstract available
    
    
    
37. HEERKENS L, van Kleef LA, de Knegt RJ, Voortman T, et al
    Fatty Liver Index and mortality after myocardial infarction: A prospective analysis in the Alpha Omega Cohort.
    PLoS One. 2023;18:e0287467.
    PubMed     Abstract available
    
    
    
38. ISMAIL FF, Md Redzuan A, Chong WW, Ahmad Nizaruddin M, et al
    Role of community pharmacists in cardiovascular diseases-related health promotion and dyslipidemia management in Malaysia: A nationwide cross-sectional study.
    PLoS One. 2023;18:e0290883.
    PubMed     Abstract available
    
    
    
39. NISHIDA Y, Anzai T, Takahashi K, Kozuma T, et al
    Multimorbidity patterns in the working age population with the top 10% medical cost from exhaustive insurance claims data of Japan Health Insurance Association.
    PLoS One. 2023;18:e0291554.
    PubMed     Abstract available
    
    
    
40. COSTA S, Guerreiro J, Teixeira I, Helling DK, et al
    Patient preferences and cost-benefit of hypertension and hyperlipidemia collaborative management model between pharmacies and primary care in Portugal: A discrete choice experiment alongside a trial (USFarmacia(R)).
    PLoS One. 2023;18:e0292308.
    PubMed     Abstract available
    
    
    
41. YADEGAR A, Mohammadi F, Rabizadeh S, Meysamie A, et al
    Decreasing trend of blood lipid profile in type 2 diabetes: Not a promising change in HDL-C, a serial cross-sectional study.
    PLoS One. 2023;18:e0293410.
    PubMed     Abstract available
    
    
    
42. SISCART J, Perejon D, Serna MC, Oros M, et al
    Prevalence, risk factors, and consequences of hypothyroidism among pregnant women in the health region of Lleida: A cohort study.
    PLoS One. 2023;18:e0278426.
    PubMed     Abstract available
    
    
    
43. MOTUMA A, Shiferaw K, Gobena T, Teji Roba K, et al
    Dyslipidemia and its predictors among adult workers in eastern Ethiopia: An institution-based cross-sectional study.
    PLoS One. 2023;18:e0291665.
    PubMed     Abstract available
    
    
    
44. SAKSERANEE J, Sethabouppha P, Pattarasakulchai T, Klaewkla T, et al
    The diagnostic tests and functional outcomes of acute ischemic stroke or transient ischemic attack in young adults: A 4-year hospital-based observational study.
    PLoS One. 2023;18:e0292274.
    PubMed     Abstract available
    
    
    
45. DIDEVAR N, Rezasoltani P, Pourgholaminejad A, Kazemnezhad Leyli E, et al
    Interleukin-17, C-reactive protein, Neutrophil-to-Lymphocyte ratio, Lymphocyte-to-Monocyte ratio, and lipid profiles in healthy menopausal women with or without hot flashes: A cross-sectional study.
    PLoS One. 2023;18:e0291804.
    PubMed     Abstract available
    
    
    
46. ALAHDAB F, El Shawi R, Ahmed AI, Han Y, et al
    Patient-level explainable machine learning to predict major adverse cardiovascular events from SPECT MPI and CCTA imaging.
    PLoS One. 2023;18:e0291451.
    PubMed     Abstract available
    
    
    
47. SINGLETON CMH, Brar S, Robertson N, DiTommaso L, et al
    Cardiometabolic risk factors in South American children: A systematic review and meta-analysis.
    PLoS One. 2023;18:e0293865.
    PubMed     Abstract available
    
    
    
48. JIA X, Zhang X, Zhou T, Sun D, et al
    Cyp3A4 *1G polymorphism is associated with alcohol drinking: A 5-year retrospective single centered population-based study in China.
    PLoS One. 2023;18:e0295184.
    PubMed     Abstract available
    
    
    
49. HARMADHA WSP, Muharram FR, Gaspar RS, Azimuth Z, et al
    Explaining the increase of incidence and mortality from cardiovascular disease in Indonesia: A global burden of disease study analysis (2000-2019).
    PLoS One. 2023;18:e0294128.
    PubMed     Abstract available
    
    
    
50. BADACHO AS, Mahomed OH
    Mapping evidence on barriers to and facilitators of diagnosing noncommunicable diseases (NCDs) among people living with human immunodeficiency virus (PLWH) in low- and middle-income countries (LMICs) in Africa: A scoping review protocol.
    PLoS One. 2023;18:e0294979.
    PubMed     Abstract available
    
    
    
51. FU W, Hu F, Xu C
    Association between red blood cell distribution width/albumin ratio and all-cause mortality or cardiovascular diseases mortality in patients with diabetic retinopathy: A cohort study.
    PLoS One. 2023;18:e0296019.
    PubMed     Abstract available
    
    
    January 2022
52. SUZUKI K, Suda G, Yamamoto Y, Abiko S, et al
    Effect of switching from tenofovir disoproxil fumarate to tenofovir alafenamide on lipid profiles in patients with hepatitis B.
    PLoS One. 2022;17:e0261760.
    PubMed     Abstract available
    
    
    
53. TIAN G, Wu Y, Jin X, Zeng Z, et al
    The incidence rate and influence factors of hemolysis, lipemia, icterus in fasting serum biochemistry specimens.
    PLoS One. 2022;17:e0262748.
    PubMed     Abstract available
    
    
    
54. MATSUNAGA T, Kadomatsu Y, Tsukamoto M, Kubo Y, et al
    Associations of breastfeeding history with metabolic syndrome and cardiovascular risk factors in community-dwelling parous women: The Japan Multi-Institutional Collaborative Cohort Study.
    PLoS One. 2022;17:e0262252.
    PubMed     Abstract available
    
    
    
55. TABATABAEI-MALAZY O, Saeedi Moghaddam S, Masinaei M, Rezaei N, et al
    Association between being metabolically healthy/unhealthy and metabolic syndrome in Iranian adults.
    PLoS One. 2022;17:e0262246.
    PubMed     Abstract available
    
    
    
56. ABURUZ S, Al-Azayzih A, ZainAlAbdin S, Beiram R, et al
    Clinical characteristics and risk factors for mortality among COVID-19 hospitalized patients in UAE: Does ethnic origin have an impact.
    PLoS One. 2022;17:e0264547.
    PubMed     Abstract available
    
    
    
57. HAMMAD EA, Al-Aqeel S, Elayah E, Jaber D, et al
    Assessing content and factors influencing responses to information requests in community pharmacies in Jordan: A simulated patients study.
    PLoS One. 2022;17:e0264224.
    PubMed     Abstract available
    
    
    
58. BHATTARAI S, Bista B, Yadav BK, Gynawali P, et al
    Estimation of mean population salt intakes using spot urine samples and associations with body mass index, hypertension, raised blood sugar and hypercholesterolemia: Findings from STEPS Survey 2019, Nepal.
    PLoS One. 2022;17:e0266662.
    PubMed     Abstract available
    
    
    
59. ANENI EC, Saeed GJ, Bittencourt MS, Cainzos-Achirica M, et al
    Cardiometabolic disorders, inflammation and the incidence of non-alcoholic fatty liver disease: A longitudinal study comparing lean and non-lean individuals.
    PLoS One. 2022;17:e0266505.
    PubMed     Abstract available
    
    
    
60. BRANAS F, Galindo MJ, Torralba M, Antela A, et al
    Different profiles among older adults with HIV according to their chronological age and the year of HIV diagnosis: The FUNCFRAIL cohort study (GeSIDA 9817).
    PLoS One. 2022;17:e0266191.
    PubMed     Abstract available
    
    
    
61. MARTINEZ CA, Rikhi R, Pester MS, Parker M, et al
    Abacavir antiretroviral therapy and indices of subclinical vascular disease in persons with HIV.
    PLoS One. 2022;17:e0264445.
    PubMed     Abstract available
    
    
    
62. AH YM, Jeong M, Choi HD
    Comparative safety and efficacy of low- or moderate-intensity statin plus ezetimibe combination therapy and high-intensity statin monotherapy: A meta-analysis of randomized controlled studies.
    PLoS One. 2022;17:e0264437.
    PubMed     Abstract available
    
    
    
63. WALDMANN E, Wu L, Busygina K, Altenhofer J, et al
    Effect of PCSK9 inhibition with evolocumab on lipoprotein subfractions in familial dysbetalipoproteinemia (type III hyperlipidemia).
    PLoS One. 2022;17:e0265838.
    PubMed     Abstract available
    
    
    
64. WANG SK, Lee MC, Hung CL, Chen HH, et al
    Association between hypertriglyceridemic waist phenotype and hypogonadism in Taiwanese adult men.
    PLoS One. 2022;17:e0265629.
    PubMed     Abstract available
    
    
    
65. HAMADA S, Takata T, Yamada K, Yamamoto M, et al
    Steatosis is involved in the progression of kidney disease in a high-fat-diet-induced non-alcoholic steatohepatitis mouse model.
    PLoS One. 2022;17:e0265461.
    PubMed     Abstract available
    
    
    
66. ERTURK ZARARSIZ G, Bolat S, Cephe A, Kochan N, et al
    Validation of Friedewald, Martin-Hopkins and Sampson low-density lipoprotein cholesterol equations.
    PLoS One. 2022;17:e0263860.
    PubMed     Abstract available
    
    
    
67. MCDONALD R, Kuhn K, Nguyen TB, Tannous A, et al
    A randomized clinical trial demonstrating cell type specific effects of hyperlipidemia and hyperinsulinemia on pituitary function.
    PLoS One. 2022;17:e0268323.
    PubMed     Abstract available
    
    
    
68. PARK YS, Ryu GW, Choi M
    Multiple metabolic comorbidities and their consequences among patients with peripheral arterial disease.
    PLoS One. 2022;17:e0268201.
    PubMed     Abstract available
    
    
    
69. AL-ASHWAL FY, Sulaiman SAS, Sheikh Ghadzi SM, Kubas MA, et al
    Risk assessment of atherosclerotic cardiovascular diseases before statin therapy initiation: Knowledge, attitude, and practice of physicians in Yemen.
    PLoS One. 2022;17:e0269002.
    PubMed     Abstract available
    
    
    
70. EFREMOV Y, Ermolaeva A, Vladimirov G, Gordleeva S, et al
    A mathematical model of in vitro hepatocellular cholesterol and lipoprotein metabolism for hyperlipidemia therapy.
    PLoS One. 2022;17:e0264903.
    PubMed     Abstract available
    
    
    
71. DE OLIVEIRA CM, Pavani JL, Liu C, Balcells M, et al
    Comparing different metabolic indexes to predict type 2 diabetes mellitus in a five years follow-up cohort: The Baependi Heart Study.
    PLoS One. 2022;17:e0267723.
    PubMed     Abstract available
    
    
    
72. ALOWAYESH MS, Aljunid SM, Al-Adsani A, Alessa T, et al
    Utilization and cost of drugs for diabetes and its comorbidities and complications in Kuwait.
    PLoS One. 2022;17:e0268495.
    PubMed     Abstract available
    
    
    
73. SHARMA S, Khudiwal A, Bhardwaj S, Chaturvedi H, et al
    Healthcare worker-based opportunistic screening for familial hypercholesterolemia in a low-resource setting.
    PLoS One. 2022;17:e0269605.
    PubMed     Abstract available
    
    
    
74. ALBUQUERQUE J, Medeiros AM, Alves AC, Bourbon M, et al
    Comparative study on the performance of different classification algorithms, combined with pre- and post-processing techniques to handle imbalanced data, in the diagnosis of adult patients with familial hypercholesterolemia.
    PLoS One. 2022;17:e0269713.
    PubMed     Abstract available
    
    
    
75. SAGACETA-MEJIA J, Tolentino-Mayo L, Cruz-Casarrubias C, Nieto C, et al
    Understanding of front of package nutrition labels: Guideline daily amount and warning labels in Mexicans with non-communicable diseases.
    PLoS One. 2022;17:e0269892.
    PubMed     Abstract available
    
    
    
76. ACHILA OO, Abrhaley F, Kesete Y, Tesfaldet F, et al
    Dyslipidemia and associated risk factors among HIV/AIDS patients on HAART in Asmara, Eritrea.
    PLoS One. 2022;17:e0270838.
    PubMed     Abstract available
    
    
    
77. CHHABRA M, Vidyasagar K, Gudi SK, Sharma J, et al
    Efficacy and safety of saroglitazar for the management of dyslipidemia: A systematic review and meta-analysis of interventional studies.
    PLoS One. 2022;17:e0269531.
    PubMed     Abstract available
    
    
    
78. JEONG W
    Association between dual smoking and dyslipidemia in South Korean adults.
    PLoS One. 2022;17:e0270577.
    PubMed     Abstract available
    
    
    
79. ELALEM EG, Jelani M, Khedr A, Ahmad A, et al
    Association of cytochromes P450 3A4*22 and 3A5*3 genotypes and polymorphism with response to simvastatin in hypercholesterolemia patients.
    PLoS One. 2022;17:e0260824.
    PubMed     Abstract available
    
    
    
80. OHYA Y, Matsuo R, Sato N, Irie F, et al
    Causes of ischemic stroke in young adults versus non-young adults: A multicenter hospital-based observational study.
    PLoS One. 2022;17:e0268481.
    PubMed     Abstract available
    
    
    
81. KHANAL MK, Bhandari P, Dhungana RR, Gurung Y, et al
    Poor glycemic control, cardiovascular disease risk factors and their clustering among patients with type 2 diabetes mellitus: A cross-sectional study from Nepal.
    PLoS One. 2022;17:e0271888.
    PubMed     Abstract available
    
    
    
82. CHENG HY, Fung E, Choi KC, Zou HJ, et al
    Early risk of acute myocardial infarction following hospitalization for severe influenza infection in the middle-aged population of Hong Kong.
    PLoS One. 2022;17:e0272661.
    PubMed     Abstract available
    
    
    
83. YU W, Gao C, Zhao X, Li C, et al
    Four-way decomposition of effect of cigarette smoking and body mass index on serum lipid profiles.
    PLoS One. 2022;17:e0270486.
    PubMed     Abstract available
    
    
    
84. NAZLI SA, Chua YA, Mohd Kasim NA, Ismail Z, et al
    Familial hypercholesterolaemia and coronary risk factors among patients with angiogram-proven premature coronary artery disease in an Asian cohort.
    PLoS One. 2022;17:e0273896.
    PubMed     Abstract available
    
    
    
85. HUNG MC, Chen YY
    Association between retinitis pigmentosa and an increased risk of primary angle closure glaucoma: A population-based cohort study.
    PLoS One. 2022;17:e0274066.
    PubMed     Abstract available
    
    
    
86. TAVOLINEJAD H, Roshani S, Rezaei N, Ghasemi E, et al
    A machine learning approach to evaluate the state of hypertension care coverage: From 2016 STEPs survey in Iran.
    PLoS One. 2022;17:e0273560.
    PubMed     Abstract available
    
    
    
87. LU Z, Li Y, Li AJ, Syn WK, et al
    Loss of GPR40 in LDL receptor-deficient mice exacerbates high-fat diet-induced hyperlipidemia and nonalcoholic steatohepatitis.
    PLoS One. 2022;17:e0277251.
    PubMed     Abstract available
    
    
    
88. SAKURADA K, Konta T, Murakami N, Kosugi N, et al
    Association between lack of sexual interest and all-cause mortality in a Japanese general population: The Yamagata prospective observational study.
    PLoS One. 2022;17:e0277967.
    PubMed     Abstract available
    
    
    
89. DINTSHI M, Kone N, Khoza S
    Comparison of measured LDL cholesterol with calculated LDL-cholesterol using the Friedewald and Martin-Hopkins formulae in diabetic adults at Charlotte Maxeke Johannesburg Academic Hospital/NHLS Laboratory.
    PLoS One. 2022;17:e0277981.
    PubMed     Abstract available
    
    
    
90. CROMER SJ, Chen V, Han C, Marshall W, et al
    Algorithmic identification of atypical diabetes in electronic health record (EHR) systems.
    PLoS One. 2022;17:e0278759.
    PubMed     Abstract available
    
    
    January 2021
91. JAYANAMA K, Srichatrapimuk S, Thammavaranucupt K, Kirdlarp S, et al
    The association between body mass index and severity of Coronavirus Disease 2019 (COVID-19): A cohort study.
    PLoS One. 2021;16:e0247023.
    PubMed     Abstract available
    
    
    
92. ARAUJO COD, Montenegro RM, Pedroso AP, Fernandes VO, et al
    Altered acylated ghrelin response to food intake in congenital generalized lipodystrophy.
    PLoS One. 2021;16:e0244667.
    PubMed     Abstract available
    
    
    
93. WONG JC, O'Neill S, Beck BR, Forwood MR, et al
    Comparison of obesity and metabolic syndrome prevalence using fat mass index, body mass index and percentage body fat.
    PLoS One. 2021;16:e0245436.
    PubMed     Abstract available
    
    
    
94. EUSWAS N, Phonnopparat N, Morasert K, Thakhampaeng P, et al
    National trends in the prevalence of diabetic retinopathy among Thai patients with type 2 diabetes and its associated factors from 2014 to 2018.
    PLoS One. 2021;16:e0245801.
    PubMed     Abstract available
    
    
    
95. GEBREEGZIABIHER G, Belachew T, Mehari K, Tamiru D, et al
    Prevalence of dyslipidemia and associated risk factors among adult residents of Mekelle City, Northern Ethiopia.
    PLoS One. 2021;16:e0243103.
    PubMed     Abstract available
    
    
    
96. AJABNOOR GMA, Bahijri S, Alamoudi AA, Al Raddadi R, et al
    The association between hypertension and other cardiovascular risk factors among non-diabetic Saudis adults-A cross sectional study.
    PLoS One. 2021;16:e0246568.
    PubMed     Abstract available
    
    
    
97. SHIN WY, Kim JH
    Poor diet quality is associated with self-reported knee pain in community-dwelling women aged 50 years and older.
    PLoS One. 2021;16:e0245630.
    PubMed     Abstract available
    
    
    
98. BLAIS JE, Tong GKY, Pathadka S, Mok M, et al
    Comparative efficacy and safety of statin and fibrate monotherapy: A systematic review and meta-analysis of head-to-head randomized controlled trials.
    PLoS One. 2021;16:e0246480.
    PubMed     Abstract available
    
    
    
99. LEE CY, Liu KT, Lu HT, Mohd Ali R, et al
    Sex and gender differences in presentation, treatment and outcomes in acute coronary syndrome, a 10 year study from a multi-ethnic Asian population: The Malaysian National Cardiovascular Disease Database-Acute Coronary Syndrome (NCVD-ACS) registry.
    PLoS One. 2021;16:e0246474.
    PubMed     Abstract available
    
    
    
100. ISHIDA S, Kondo S, Funakoshi S, Satoh A, et al
     White blood cell count and incidence of hypertension in the general Japanese population: ISSA-CKD study.
     PLoS One. 2021;16:e0246304.
     PubMed     Abstract available
     
     
     
101. DADACHANJI R, Patil A, Joshi B, Mukherjee S, et al
     Elucidating the impact of obesity on hormonal and metabolic perturbations in polycystic ovary syndrome phenotypes in Indian women.
     PLoS One. 2021;16:e0246862.
     PubMed     Abstract available
     
     
     
102. BEHBEHANI R, Ali A, Al-Moosa A
     Risk factors and visual outcome of Non-Arteritic Ischemic Optic Neuropathy (NAION): Experience of a tertiary center in Kuwait.
     PLoS One. 2021;16:e0247126.
     PubMed     Abstract available
     
     
     
103. TANNOUS A, Bradford AP, Kuhn K, Fought A, et al
     A randomised trial examining inflammatory signaling in acutely induced hyperinsulinemia and hyperlipidemia in normal weight women-the reprometabolic syndrome.
     PLoS One. 2021;16:e0247638.
     PubMed     Abstract available
     
     
     
104. EUM MJ, Jung HS
     The interplay of sleep duration, working hours, and obesity in Korean male workers: The 2010-2015 Korea National Health and Nutrition Examination Survey.
     PLoS One. 2021;16:e0247746.
     PubMed     Abstract available
     
     
     
105. KIM JB, Song WH, Park JS, Youn TJ, et al
     A randomized, open-label, parallel, multi-center Phase IV study to compare the efficacy and safety of atorvastatin 10 and 20 mg in high-risk Asian patients with hypercholesterolemia.
     PLoS One. 2021;16:e0245481.
     PubMed     Abstract available
     
     
     
106. DE BACKER T, Van Nieuwenhuyse B, De Bacquer D
     Antihypertensive treatment in a general uncontrolled hypertensive population in Belgium and Luxembourg in primary care: Therapeutic inertia and treatment simplification. The SIMPLIFY study.
     PLoS One. 2021;16:e0248471.
     PubMed     Abstract available
     
     
     
107. TRAN DT, Lekhak N, Gutierrez K, Moonie S, et al
     Risk factors associated with cardiovascular disease among adult Nevadans.
     PLoS One. 2021;16:e0247105.
     PubMed     Abstract available
     
     
     
108. VIMALESWARAN KS, Bodhini D, Jiang J, Ramya K, et al
     Circulating adiponectin mediates the association between omentin gene polymorphism and cardiometabolic health in Asian Indians.
     PLoS One. 2021;16:e0238555.
     PubMed     Abstract available
     
     
     
109. HAN KT, Kim S
     Do cholesterol levels and continuity of statin use affect colorectal cancer incidence in older adults under 75 years of age?
     PLoS One. 2021;16:e0250716.
     PubMed     Abstract available
     
     
     
110. KIM SH, Jeong JB, Kang J, Ahn DW, et al
     Association between sarcopenia level and metabolic syndrome.
     PLoS One. 2021;16:e0248856.
     PubMed     Abstract available
     
     
     
111. LEE DH, Sheen SH, Lee DG, Jang JW, et al
     Association between ischemic stroke and seropositive rheumatoid arthritis in Korea: A nationwide longitudinal cohort study.
     PLoS One. 2021;16:e0251851.
     PubMed     Abstract available
     
     
     
112. GURM Z, Seth M, Daher E, Pielsticker E, et al
     Prevalence of coronary risk factors in contemporary practice among patients undergoing their first percutaneous coronary intervention: Implications for primary prevention.
     PLoS One. 2021;16:e0250801.
     PubMed     Abstract available
     
     
     
113. ALHABIB KF, Al-Rasadi K, Almigbal TH, Batais MA, et al
     Familial Hypercholesterolemia in the Arabian Gulf Region: Clinical results of the Gulf FH Registry.
     PLoS One. 2021;16:e0251560.
     PubMed     Abstract available
     
     
     
114. NIGUSSIE S, Birhan N, Amare F, Mengistu G, et al
     Rate of glycemic control and associated factors among type two diabetes mellitus patients in Ethiopia: A cross sectional study.
     PLoS One. 2021;16:e0251506.
     PubMed     Abstract available
     
     
     
115. KIM SJ, Kwon OD, Lee EJ, Ock SM, et al
     Impact of a family history of cardiovascular disease on prevalence, awareness, treatment, control of dyslipidemia, and healthy behaviors: Findings from the Korea National Health and Nutrition Examination Survey.
     PLoS One. 2021;16:e0254907.
     PubMed     Abstract available
     
     
     
116. GAO H, Wang H, Shan G, Liu R, et al
     Prevalence of dyslipidemia and associated risk factors among adult residents of Shenmu City, China.
     PLoS One. 2021;16:e0250573.
     PubMed     Abstract available
     
     
     
117. ALSUWAILEM B, Zamzam A, Syed MH, Greco E, et al
     Elevated plasma levels of NT-proBNP in ambulatory patients with peripheral arterial disease.
     PLoS One. 2021;16:e0253792.
     PubMed     Abstract available
     
     
     
118. HARA K, Kobayashi Y, Tomio J, Ito Y, et al
     Claims-based algorithms for common chronic conditions were efficiently constructed using machine learning methods.
     PLoS One. 2021;16:e0254394.
     PubMed     Abstract available
     
     
     
119. ACCARDO A, Silveri G, Ajcevic M, Miladinovic A, et al
     Influence of smoking and other cardiovascular risk factors on heart rate circadian rhythm in normotensive and hypertensive subjects.
     PLoS One. 2021;16:e0257660.
     PubMed     Abstract available
     
     
     
120. WASIELICA-POSLEDNIK J, Hampel U, Ries L, Faysal R, et al
     Prevalence of corneal arcus and associated factors in a German population-Results from the Gutenberg Health Study.
     PLoS One. 2021;16:e0255893.
     PubMed     Abstract available
     
     
     
121. NIEDZIELSKI M, Broncel M, Gorzelak-Pabis P, Wozniak E, et al
     A comparison of the effects of monotherapy with rosuvastatin, atorvastatin or ezetimibe versus combination treatment with rosuvastatin-ezetimibe and atorvastatin-ezetimibe on the integrity of vascular endothelial cells damaged by oxidized cholesterol.
     PLoS One. 2021;16:e0256996.
     PubMed     Abstract available
     
     
     
122. HATMAL MM, Alshaer W, Mahmoud IS, Al-Hatamleh MAI, et al
     Investigating the association of CD36 gene polymorphisms (rs1761667 and rs1527483) with T2DM and dyslipidemia: Statistical analysis, machine learning based prediction, and meta-analysis.
     PLoS One. 2021;16:e0257857.
     PubMed     Abstract available
     
     
     
123. SABRY M, Mostafa S, Kamar S, Rashed L, et al
     The cross-talk between matrix metalloproteinase-9, RANKL/OPG system and cardiovascular risk factors in ovariectomized rat model of postmenopausal osteoporosis.
     PLoS One. 2021;16:e0258254.
     PubMed     Abstract available
     
     
     
124. AKINMOLAYEMI O, Saldanha S, Joshi PH, Deodhar S, et al
     Cholesterol efflux capacity and its association with prevalent metabolic syndrome in a multi-ethnic population (Dallas Heart Study).
     PLoS One. 2021;16:e0257574.
     PubMed     Abstract available
     
     
     
125. LIU J, Chen Y, Jin C, Chen D, et al
     Analysis of prevalence and influencing factors of stroke in elderly hypertensive patients: Based on the screening plan for the high-risk population of stroke in Jiading District, Shanghai.
     PLoS One. 2021;16:e0255279.
     PubMed     Abstract available
     
     
     
126. FERRIERES J, Banks V, Pillas D, Giorgianni F, et al
     Screening and treatment of familial hypercholesterolemia in a French sample of ambulatory care patients: A retrospective longitudinal cohort study.
     PLoS One. 2021;16:e0255345.
     PubMed     Abstract available
     
     
     
127. FERRARA P, Di Laura D, Cortesi PA, Mantovani LG, et al
     The economic impact of hypercholesterolemia and mixed dyslipidemia: A systematic review of cost of illness studies.
     PLoS One. 2021;16:e0254631.
     PubMed     Abstract available
     
     
     
128. LEE KI, In SM, Kim JY, Hong JY, et al
     Association of nasal septal deviation with the incidence of anxiety, depression, and migraine: A national population-based study.
     PLoS One. 2021;16:e0259468.
     PubMed     Abstract available
     
     
     
129. ABATE TW, Zeleke B, Genanew A, Abate BW, et al
     The burden of stroke and modifiable risk factors in Ethiopia: A systemic review and meta-analysis.
     PLoS One. 2021;16:e0259244.
     PubMed     Abstract available
     
     
     
130. URASHIMA K, Miramontes A, Garcia LA, Coletta DK, et al
     Potential evidence for epigenetic biomarkers of metabolic syndrome in human whole blood in Latinos.
     PLoS One. 2021;16:e0259449.
     PubMed     Abstract available
     
     
     
131. GEBREMEDHIN MH, Lake EA, Gebrekirstos LG
     Heavy khat (Catha edulis) chewing and dyslipidemia as modifiable hypertensive risk factors among patients in Southwest, Ethiopia: Unmatched case-control study.
     PLoS One. 2021;16:e0259078.
     PubMed     Abstract available
     
     
     
132. SQUIER K, Scott A, Hunt MA, Brunham LR, et al
     The effects of cholesterol accumulation on Achilles tendon biomechanics: A cross-sectional study.
     PLoS One. 2021;16:e0257269.
     PubMed     Abstract available
     
     
     
133. WATANABE H, Takenouchi K, Kimura M
     MIHARI project, a preceding study of MID-NET, adverse event detection database of Ministry Health of Japan-Validation study of the signal detection of adverse events of drugs using export data from EMR and medical claim data.
     PLoS One. 2021;16:e0255863.
     PubMed     Abstract available
     
     
     
134. KIM SH, Kang HW, Jeong JB, Lee DS, et al
     Association of obesity, visceral adiposity, and sarcopenia with an increased risk of metabolic syndrome: A retrospective study.
     PLoS One. 2021;16:e0256083.
     PubMed     Abstract available
     
     
     
135. LIM CY, Ho JS, Huang Z, Gao F, et al
     Public perceptions and knowledge of cholesterol management in a multi-ethnic Asian population: A population-based survey.
     PLoS One. 2021;16:e0256218.
     PubMed     Abstract available
     
     
     
136. WU Y, Peng T, Chen Y, Huang L, et al
     Acupuncture for glucose and lipid metabolic disorders of polycystic ovarian syndrome: A systematic review protocol.
     PLoS One. 2021;16:e0255732.
     PubMed     Abstract available
     
     
     
137. GUO X, Zhao B, Chen T, Hao B, et al
     Multimorbidity in the elderly in China based on the China Health and Retirement Longitudinal Study.
     PLoS One. 2021;16:e0255908.
     PubMed     Abstract available
     
     
     
138. ALFAIFI AA, Lai L, Althemery AU
     Barriers in utilizing lipid-lowering agents in non-institutionalized population in the U.S.: Application of a theoretical framework.
     PLoS One. 2021;16:e0255729.
     PubMed     Abstract available
     
     
     
139. DESHYCKA R, Sudaryo V, Huang NJ, Xie Y, et al
     Engineered red blood cells carrying PCSK9 inhibitors persistently lower LDL and prevent obesity.
     PLoS One. 2021;16:e0259353.
     PubMed     Abstract available
     
     
     
140. PULIPATI VP, Amblee A, Yap SET, Shaka H, et al
     Hypertriglyceridemia-associated acute pancreatitis: Response to continuous insulin infusion.
     PLoS One. 2021;16:e0260495.
     PubMed     Abstract available
     
     
     
141. LEE S, Yang S, Chang MJ
     Antihypertensive effects of rosuvastatin in patients with hypertension and dyslipidemia: A systemic review and meta-analysis of randomized studies.
     PLoS One. 2021;16:e0260391.
     PubMed     Abstract available
     
     
     
142. LEE Y, Shin J, Kim Y, Kim DS, et al
     Consumption of single products versus fixed-dose combination medicines for hypertension and hyperlipidemia during 2015-2019 in South Korea.
     PLoS One. 2021;16:e0259467.
     PubMed     Abstract available
     
     
     
143. ANDERSON K, Bavishi C, Kolte D, Gohh R, et al
     Relation of abnormal cardiac stress testing with outcomes in patients undergoing renal transplantation.
     PLoS One. 2021;16:e0260718.
     PubMed     Abstract available
     
     
     
144. JOO YH, Lee HJ, Park JO, Seo YJ, et al
     The risk of laryngitis with herpes zoster infection: A nested case-control study using data from the Korean National Sample Cohort.
     PLoS One. 2021;16:e0261366.
     PubMed     Abstract available
     
     
     
145. BUSCH C, Katzmann JL, Jochmann C, Unterlauft JD, et al
     General health of patients with diabetic macular edema-The LIPSIA study.
     PLoS One. 2021;16:e0252321.
     PubMed     Abstract available
     
     
     
146. DIECI M, Llibre-Rodriguez JJ, Acosta D, Dow WH, et al
     Cuba's cardiovascular risk factors: International comparison of levels and education gradients.
     PLoS One. 2021;16:e0247831.
     PubMed     Abstract available
     
     
     January 2020
147. NAKAMORI M, Imamura E, Fukuta M, Tachiyama K, et al
     Tongue thickness measured by ultrasonography is associated with tongue pressure in the Japanese elderly.
     PLoS One. 2020;15:e0230224.
     PubMed     Abstract available
     
     
     
148. KHALIL MI, Salwa M, Sultana S, Al Mamun MA, et al
     Role of serum uric acid in ischemic stroke: A case-control study in Bangladesh.
     PLoS One. 2020;15:e0236747.
     PubMed     Abstract available
     
     
     
149. LEE HJ, Kim CO, Lee DC
     Association between daily sunlight exposure duration and diabetic retinopathy in Korean adults with diabetes: A nationwide population-based cross-sectional study.
     PLoS One. 2020;15:e0237149.
     PubMed     Abstract available
     
     
     
150. KAUR S U, Oyeyemi BF, Shet A, Gopalan BP, et al
     Plasma metabolomic study in perinatally HIV-infected children using 1H NMR spectroscopy reveals perturbed metabolites that sustain during therapy.
     PLoS One. 2020;15:e0238316.
     PubMed     Abstract available
     
     
     
151. LEE JH, Song DY, Jun SH, Song SH, et al
     High prevalence of increased sitosterol levels in hypercholesterolemic children suggest underestimation of sitosterolemia incidence.
     PLoS One. 2020;15:e0238079.
     PubMed     Abstract available
     
     
     
152. KAPOOR N, Lotfaliany M, Sathish T, Thankappan KR, et al
     Prevalence of normal weight obesity and its associated cardio-metabolic risk factors - Results from the baseline data of the Kerala Diabetes Prevention Program (KDPP).
     PLoS One. 2020;15:e0237974.
     PubMed     Abstract available
     
     
     
153. LIU KL, Tsai WC, Tu HP, Lee CH, et al
     Statin use and the risk of chronic kidney disease in patients with psoriasis: A nationwide cohort study in Taiwan.
     PLoS One. 2020;15:e0237816.
     PubMed     Abstract available
     
     
     
154. KIM T, Choi H, Kang J, Kim J, et al
     Association between electronic cigarette use and metabolic syndrome in the Korean general population: A nationwide population-based study.
     PLoS One. 2020;15:e0237983.
     PubMed     Abstract available
     
     
     
155. KYPRIANIDOU M, Panagiotakos D, Faka A, Kambanaros M, et al
     Prevalence of multimorbidity in the Cypriot population; A cross-sectional study (2018-2019).
     PLoS One. 2020;15:e0239835.
     PubMed     Abstract available
     
     
     
156. IZCOVICH A, Ragusa MA, Tortosa F, Lavena Marzio MA, et al
     Prognostic factors for severity and mortality in patients infected with COVID-19: A systematic review.
     PLoS One. 2020;15:e0241955.
     PubMed     Abstract available
     
     
     
157. THOMAS R, Spence MT, Roy R, Beller E, et al
     A randomised on-line survey exploring how health condition labels affect behavioural intentions.
     PLoS One. 2020;15:e0240985.
     PubMed     Abstract available
     
     
     
158. MIETUS-SNYDER M, Narayanan N, Krauss RM, Laine-Graves K, et al
     Randomized nutrient bar supplementation improves exercise-associated changes in plasma metabolome in adolescents and adult family members at cardiometabolic risk.
     PLoS One. 2020;15:e0240437.
     PubMed     Abstract available
     
     
     
159. VERONEZE R, Cruz Tfaile Corbi S, Roque da Silva B, de S Rocha C, et al
     Using association rule mining to jointly detect clinical features and differentially expressed genes related to chronic inflammatory diseases.
     PLoS One. 2020;15:e0240269.
     PubMed     Abstract available
     
     
     
160. SINGH G, Hussain Y, Xu Z, Sholle E, et al
     Comparing a novel machine learning method to the Friedewald formula and Martin-Hopkins equation for low-density lipoprotein estimation.
     PLoS One. 2020;15:e0239934.
     PubMed     Abstract available
     
     
     
161. BORKOWSKI K, Newman JW, Aghaeepour N, Mayo JA, et al
     Mid-gestation serum lipidomic profile associations with spontaneous preterm birth are influenced by body mass index.
     PLoS One. 2020;15:e0239115.
     PubMed     Abstract available
     
     
     
162. CHO JH, Lim YC, Han KD, Lee JY, et al
     The incidence of malignant brain tumors is increased in patients with obstructive sleep apnea: A national health insurance survey.
     PLoS One. 2020;15:e0241598.
     PubMed     Abstract available
     
     
     
163. MAIGA Y, Diallo S, Konipo FDN, Sangho O, et al
     Diabetic polyneuropathy with/out neuropathic pain in Mali: A cross-sectional study in two reference diabetes treatment centers in Bamako (Mali), Western Africa.
     PLoS One. 2020;15:e0241387.
     PubMed     Abstract available
     
     
     
164. BOVE KB, Nilsson M, Pedersen LR, Mikkelsen N, et al
     Comprehensive treatment of microvascular angina in overweight women - a randomized controlled pilot trial.
     PLoS One. 2020;15:e0240722.
     PubMed     Abstract available
     
     
     
165. ZOU Y, Sheng G, Yu M, Xie G, et al
     The association between triglycerides and ectopic fat obesity: An inverted U-shaped curve.
     PLoS One. 2020;15:e0243068.
     PubMed     Abstract available
     
     
     
166. ANANTHAKUMAR A, Liu Y, Fernandez CE, Truskey GA, et al
     Modeling statin myopathy in a human skeletal muscle microphysiological system.
     PLoS One. 2020;15:e0242422.
     PubMed     Abstract available
     
     
     
167. HARBER MP, Metz M, Peterman JE, Whaley MH, et al
     Trends in cardiorespiratory fitness among apparently healthy adults from the Ball State Adult Fitness Longitudinal Lifestyle STudy (BALL ST) cohort from 1970-2019.
     PLoS One. 2020;15:e0242995.
     PubMed     Abstract available
     
     
     
168. JONES LK, Sturm AC, Seaton TL, Gregor C, et al
     Barriers, facilitators, and solutions to familial hypercholesterolemia treatment.
     PLoS One. 2020;15:e0244193.
     PubMed     Abstract available
     
     
     
169. SEMMLER G, Bachmayer S, Wernly S, Wernly B, et al
     Nut consumption and the prevalence and severity of non-alcoholic fatty liver disease.
     PLoS One. 2020;15:e0244514.
     PubMed     Abstract available
     
     
     
170. PAWLOS A, Broncel M, Wlazlowska E, Jablonowska E, et al
     Cardiovascular risk and response to lipid lowering therapy in patients with HIV infection according to different recommendations.
     PLoS One. 2020;15:e0244675.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Dyslipidemia is free of charge.